These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29527025)

  • 1. Clinical and Histopathological Response to Multidrug Therapy in Paucibacillary Leprosy at the end of 6 Months: A Prospective Observational Study from Eastern India.
    Podder I; Saha A; Bandyopadhyay D
    Indian J Dermatol; 2018; 63(1):47-52. PubMed ID: 29527025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histopathological features of paucibacillary leprosy before and after multidrug therapy: a prospective study.
    Jain S; Ramesh V; Singh A; Yadav A; Ramam M; Khandpur S
    Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):350-8. PubMed ID: 27317754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A; Girdhar A; Girdhar BK
    Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
    Rao PN; Suneetha S; Pratap DV
    Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
    Dasananjali K; Schreuder PA; Pirayavaraporn C
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment.
    Prasad PV; Babu A; Kaviarasan PK; Viswanathan P; Tippoo R
    Indian J Dermatol Venereol Leprol; 2005; 71(4):242-5. PubMed ID: 16394431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
    Rao PN; Suneetha S; Pratap DV
    Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches in the treatment of Hansen's disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.
    Franco-Paredes C; Garcia-Creighton E; Henao-Martínez A; Kallgren DL; Banjade R; Dyer JA; Nelson T; Zaesim A; Peluso MJ; Jain V; Lee DH; Minces LR; Wirshup M; Sierra Hoffman M; Katsolis J; Brust K; Giron J; Smiarowski L; Hoosepian-Mer PA; Stryjewska B
    Ther Adv Infect Dis; 2022; 9():20499361221135885. PubMed ID: 36387060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study.
    Kumar A; Girdhar A; Girdhar BK
    BMJ Open; 2012; 2(4):. PubMed ID: 22893667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile of leprosy patients: a prospective study.
    Thakkar S; Patel SV
    Indian J Dermatol; 2014 Mar; 59(2):158-62. PubMed ID: 24700934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M; Gupte MD
    Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinico-pathological study of multidrug regimen in paucibacillary leprosy.
    Kar PK; Jha PK; Panayach JS; Snehi PS
    Indian J Lepr; 1988 Apr; 60(2):235-41. PubMed ID: 3192972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
    Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
    Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histopathological activity in paucibacillary leprosy patients after fixed-duration multidrug therapy.
    Ebenezer GJ; Suneetha S; Arunthathi S
    Lepr Rev; 1997 Sep; 68(3):218-24. PubMed ID: 9364822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy.
    Kamal R; Natrajan M; Katoch K; Arora M
    Indian J Lepr; 2012; 84(4):287-306. PubMed ID: 23720894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
    Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
    Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.